Cite

HARVARD Citation

    Cao, X. et al. (2021). Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer. Journal for immunotherapy of cancer. 9 (3), p. . [Online]. 
  
Back to record